Analysis of Inhaled Corticoid Prescriptions in General Medicine

Asthma Clinical Trial

— COMEGE  

Official title:

Analysis of Inhaled Corticoid Prescriptions in General Medicine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03179826
• Other study ID #: RECHMPL17-0152
• Secondary ID: 2017-A01230-53
• Status: Completed
• Start date: July 13, 2017
• Est. completion date: December 31, 2018

Study information

• Verified date: April 2019
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Chronic obstructive pulmonary disease (COPD) and asthma are frequent and disabling pathologies. The general practitioner is often at the front line vis-a-vis screening, diagnosis and treatment of these pathologies. There are currently many treatments available, in particular inhaled corticosteroids, and although the recommendations for management appear to be well codified in theory, the adaptation of drug therapy remains complex in general practice.

The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice.

The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available.

The secondary objectives are:

• Identify other factors associated with decision-making

• Identify the causes of inhaled corticosteroid stopping (de-prescription)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: December 31, 2018
• Est. primary completion date: July 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient with short-term inhaled corticosteroid therapy

• Informed and not opposed to participate in this research

Exclusion Criteria:

• Patient under judicial or legal protection

• Adults under any kind of guardianship -

Related Conditions & MeSH terms

• Asthma
• Chronic Obstructive Pulmonary Disease
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Locations

Country	Name	City	State
France	Cabinet de médecine générale	Clapiers
France	Cabinet de médecine générale	St Martin de Londres

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of all factors justifying the prescription of inhaled cortcoids	The presence (yes/no) of all factors justifying the prescription of inhaled cortcoids as described in the associated market authorization.	Day 0 (transversal study)